COLOMBO, Antonio
 Distribuzione geografica
Continente #
AS - Asia 4.277
NA - Nord America 4.185
SA - Sud America 929
EU - Europa 777
AF - Africa 102
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.277
Nazione #
US - Stati Uniti d'America 4.031
SG - Singapore 2.591
CN - Cina 794
BR - Brasile 761
VN - Vietnam 394
IE - Irlanda 183
FI - Finlandia 157
HK - Hong Kong 109
IT - Italia 83
IN - India 77
GB - Regno Unito 70
DE - Germania 68
AR - Argentina 61
CA - Canada 56
BD - Bangladesh 55
MX - Messico 52
FR - Francia 46
IQ - Iraq 32
TR - Turchia 31
PK - Pakistan 29
ZA - Sudafrica 28
RU - Federazione Russa 24
PL - Polonia 23
SE - Svezia 23
UA - Ucraina 23
EC - Ecuador 21
JP - Giappone 20
NL - Olanda 20
CO - Colombia 19
VE - Venezuela 18
CL - Cile 17
ID - Indonesia 16
PY - Paraguay 16
MA - Marocco 15
AE - Emirati Arabi Uniti 14
KE - Kenya 13
UZ - Uzbekistan 13
ES - Italia 12
JO - Giordania 10
MY - Malesia 10
NG - Nigeria 10
PH - Filippine 10
CR - Costa Rica 9
TW - Taiwan 8
AL - Albania 7
DO - Repubblica Dominicana 7
DZ - Algeria 7
AZ - Azerbaigian 6
JM - Giamaica 6
OM - Oman 6
PE - Perù 6
SA - Arabia Saudita 6
UY - Uruguay 6
ET - Etiopia 5
GT - Guatemala 5
PR - Porto Rico 5
RO - Romania 5
AT - Austria 4
AU - Australia 4
BO - Bolivia 4
CY - Cipro 4
GE - Georgia 4
HN - Honduras 4
IL - Israele 4
KZ - Kazakistan 4
LT - Lituania 4
NP - Nepal 4
PA - Panama 4
PS - Palestinian Territory 4
BE - Belgio 3
BY - Bielorussia 3
CZ - Repubblica Ceca 3
EG - Egitto 3
KG - Kirghizistan 3
LB - Libano 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
AM - Armenia 2
AO - Angola 2
BN - Brunei Darussalam 2
CI - Costa d'Avorio 2
DK - Danimarca 2
GH - Ghana 2
HU - Ungheria 2
KH - Cambogia 2
NI - Nicaragua 2
PT - Portogallo 2
RS - Serbia 2
SN - Senegal 2
TH - Thailandia 2
UG - Uganda 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
CG - Congo 1
CM - Camerun 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
Totale 10.258
Città #
Singapore 1.021
Ashburn 926
San Jose 760
The Dalles 453
Shanghai 360
New York 248
Boardman 204
Dallas 195
Dublin 183
Helsinki 157
Ho Chi Minh City 131
Beijing 126
Los Angeles 124
Hanoi 111
Hong Kong 98
São Paulo 77
Santa Clara 74
Buffalo 46
Seattle 41
Chandler 38
Wilmington 23
Council Bluffs 21
Mexico City 21
Warsaw 21
Brooklyn 19
Brasília 18
Chennai 18
Johannesburg 18
Montreal 18
Phoenix 18
Rio de Janeiro 18
Chicago 17
Assago 16
Curitiba 16
Pune 16
Tokyo 16
Da Nang 15
London 15
Charlotte 14
Toronto 14
Baghdad 12
Nairobi 12
Atlanta 11
Boston 11
Orem 11
Porto Alegre 11
Can Tho 10
Frankfurt am Main 10
Haiphong 10
Manchester 10
Quito 10
Amsterdam 9
Ankara 9
Benin City 9
Guarulhos 9
Reston 9
Rome 9
San Francisco 9
San Mateo 9
Stockholm 9
Tashkent 9
Buenos Aires 8
Hillsboro 8
Hải Dương 8
Moscow 8
Naples 8
Recife 8
Uberlândia 8
Belo Horizonte 7
Bến Tre 7
Campo Grande 7
Guangzhou 7
Manaus 7
Pasadena 7
San José 7
Santiago 7
Amman 6
Ann Arbor 6
Caxias do Sul 6
Denver 6
Dhaka 6
Kuala Lumpur 6
Kyiv 6
Lahore 6
Lauterbourg 6
Milan 6
Munich 6
Muscat 6
Natal 6
Osasco 6
Paris 6
Santo Domingo 6
Sorocaba 6
Turin 6
Baku 5
Blumenau 5
Columbus 5
Dubai 5
Düsseldorf 5
Fortaleza 5
Totale 6.183
Nome #
Coronary Artery Dissection in Drug-Coated Balloon Angioplasty: Incidence, Predictors, and Clinical Outcomes 96
A Propensity Score Matched Comparative Study Between Paclitaxel-Coated Balloon and Everolimus-Eluting Stents for the Treatment of Small Coronary Vessels 95
Clinical and Technical Challenges of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Implantation 92
P2Y12 Inhibitors Monotherapy in Patients Undergoing Complex vs Non-Complex Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials 91
12 months outcomes after Bioresorbable Vascular Scaffold implantation in Patients with Acute Coronary Syndromes. Data from the European Multicentre GHOST-EU Extended Registry 83
Acute heart failure management in a young patient requiring complex left main percutaneous coronary intervention, Impella 2.5 and transcatheter aortic valve implantation 81
Analysis of a Low Dose Protocol to Reduce Patient Radiation Exposure During Percutaneous Coronary Interventions 79
Is Transcatheter Aortic Valve Replacement Superior to Surgical Aortic Valve Replacement? A Meta-Analysis of Randomized Controlled Trials. 77
A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience 76
Implantation of contemporary transcatheter aortic valves in small aortic annuli: the international multicentre TAVI-SMALL 2 registry 74
A hybrid strategy with bioresorbable vascular scaffolds and drug eluting stents for treating complex coronary lesions 72
A Comparison Between New Generation And First Generation Transcatheter Aortic Valve Implantation (TAVI) Devices: A Single Centre Experience 72
Cardiac and sudden death after chronic total occlusion percutaneous coronary intervention: Prognostic role of the target vessel 70
Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials 67
[Saphenous vein graft aneurysm: percutaneous exclusion using detachable coils] 67
Acute and long-term (2-years) clinical outcomes of the CoreValve 31 mm in large aortic annuli: A multicenter study 67
The role of different mechanical circulatory support devices and their timing of implantation on myocardial damage and mid-term recovery in acute myocardial infarction related cardiogenic shock 65
Advances in percutaneous interventional therapies: The tricuspid valve 65
A novel maneuver to facilitate retrograde wire externalization during retrograde chronic total occlusion percutaneous coronary intervention 64
Risk of Early Adverse Events After Clopidogrel Discontinuation in Patients Undergoing Short-Term Dual Antiplatelet Therapy: An Individual Participant Data Analysis 64
Safety and efficacy of polymer-free drug-eluting stents: Amphilimus-eluting Cre8 versus biolimus-eluting biofreedom stents 64
[Severe coronary artery disease and severely impaired renal function. Focused fluid expansion and ultra-low dose contrast medium administration] 63
The Placebo Effect on Symptoms, Quality of Life, and Functional Outcomes in Patients With Angina Pectoris: A Meta-analysis of Randomized Placebo-Controlled Trials 63
Accuracy and reproducibility of aortic annular measurements obtained from echocardiographic 3D manual and semi-automated software analyses in patients referred for transcatheter aortic valve implantation: implication for prosthesis size selection 62
Transcatheter treatment of severe tricuspid regurgitation with the edge-to-edge mitraclip technique 60
Endovascular treatment of a noninfected anastomotic juxtarenal aortic aneurysm 59
A Case of Very Late (3 Years) Transcatheter Heart Valve Thrombosis 59
Outcome after percutaneous edge-to-edge mitral repair for functional and degenerative mitral regurgitation: a systematic review and meta-analysis 58
The coronary sinus reducer: clinical evidence and technical aspects 58
Anatomic and procedural associations of transcatheter heart valve displacement following Evolut R implantation 58
Transcatheter Self-Expandable Valve Implantation for Aortic Stenosis in Small Aortic Annuli The TAVI-SMALL Registry 58
Unprotected left main revascularization: Percutaneous coronary intervention versus coronary artery bypass. An updated systematic review and meta-analysis of randomised controlled trials 57
6 Months’ Follow-Up of the First-in-Man Implantation of a Novel Tricuspid Flow Optimizer 57
A Novel Technique for Prosthetic Valve Retrieval After Transcatheter Aortic Valve Embolization 57
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in all-comers population. Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 56
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in diabetic patients: Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 55
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry 54
Impact of Mitral Annular Calcium on Outcomes after Transcatheter Aortic Valve Implantation 54
One-year clinical outcome of amphilimus polymer-free drug-eluting stent in diabetes mellitus patients: Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTre rEgistry) 54
Transcatheter Aortic Valve Implantation in Patients With Advanced Chronic Kidney Disease 53
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients presenting with acute myocardial infarction: Insight from the ULISSE registry 53
Midterm and one-year outcome of amphilimus polymer free drug eluting stent in patients needing short dual antiplatelet therapy. Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTer rEgistry) 53
Predictors and Clinical Impact of Prosthesis-Patient Mismatch After Self-Expandable TAVR in Small Annuli 53
State of the art: Evolving concepts in the treatment of heavily calcified and undilatable coronary stenoses - From debulking to plaque modification, a 40-year-long journey 53
Edge-to-edge percutaneous mitral repair for functional ischaemic and non-ischaemic mitral regurgitation: a systematic review and meta-analysis 53
Multimodality imaging of the tricuspid valve with implication for percutaneous repair approaches 52
Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stentsâ Cardiogroup III Study) 52
Effect of Chronic Kidney Disease on 5-Year Outcome in Patients With Heart Failure and Secondary Mitral Regurgitation Undergoing Percutaneous MitraClip Insertion 52
The impact of the coronary sinus reducer upon left ventricular function in patients with refractory angina pectoris 51
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry 51
Patterns and associations between DAPT cessation and 2-year clinical outcomes in left main/proximal LAD versus other PCI: Results from the Patterns of Non-Adherence to Dual Antiplatelet Therapy in Stented Patients (PARIS) registry 51
Mechanism and Implications of the Tricuspid Regurgitation: From the Pathophysiology to the Current and Future Therapeutic Options 51
Clinical Outcomes With a Repositionable Self-Expanding Transcatheter Aortic Valve Prosthesis: The International FORWARD Study 51
Mitraclip therapy and surgical mitral repair in patients with moderate to severe left ventricular failure causing functional mitral regurgitation: a single-centre experience 51
Repeat MitraClip for early recurrent mitral regurgitation 51
A Fully Percutaneous Transeptal Transcatheter Mitral Valve Replacement With a Novel Device 51
Contrast-Induced Nephropathy After Percutaneous Coronary Intervention for Chronic Total Occlusion Versus Non-Occlusive Coronary Artery Disease 51
A computed tomography study of coronary access and coronary obstruction after redo transcatheter aortic valve implantation 51
Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registry 51
Key Imaging Factors for Transcatheter Management of Tricuspid Regurgitation: Device and Patient Selection 50
Mid-term clinical outcomes of ABSORB bioresorbable vascular scaffold versus everolimus-eluting stent for coronary bifurcation lesions 50
Concomitant implantation of Impella® on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock 50
Prognostic value of tricuspid regurgitation 50
Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: A systematic review and meta-analysis 50
Intraarterial thrombolysis for treatment of peripheral graft thrombosis: advantage of the radial approach 49
Cardioband, a transcatheter surgical-like direct mitral valve annuloplasty system: Early results of the feasibility trial 49
Impact of coronary artery disease in elderly patients undergoing transcatheter aortic valve implantation: Insight from the Italian CoreValve Registry 49
Transcatheter Mitral Annuloplasty in Chronic Functional Mitral Regurgitation: 6-Month Results With the Cardioband Percutaneous Mitral Repair System 49
Procedural and Long-Term Outcomes of Percutaneous Coronary Intervention for In-Stent Chronic Total Occlusion 49
Which is the best anti-aggregant or anti-coagulant therapy after TAVI? A propensity matched analysis from the ITER registry. The management of DAPT after TAVI 49
Long-term outcomes after transcatheter aortic valve implantation from a single high-volume center (The Milan Experience) 48
Percutaneous Plug-Based Arteriotomy Closure Device for Large-Bore Access: A Multicenter Prospective Study 48
Ultrasound-accelerated thrombolysis and extracorporeal membrane oxygenation in a patient with massive pulmonary embolism and cardiac arrest 48
Risk of cardiac and sudden death with and without revascularisation of a coronary chronic total occlusion 48
Relation of various plasma growth factor levels in patients with stable angina pectoris and total occlusion of a coronary artery to the degree of coronary collaterals 48
Hypertrophic Left Ventricle With Small Cavity and Severe Aortic Angulation: A Dangerous Association in Case of Transcatheter Aortic Valve Replacement 48
Prolonged Ultrasound-Assisted Catheter-Directed Low-Dose Thrombolysis for Acute Pulmonary Embolism Unresponsive to Systemic Thrombolysis 48
Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry) 48
Feasibility of ultra-low contrast 64-slice computed tomography angiography before transcatheter aortic valve implantation: A real-world experience 48
Does the STS-PROM Score or the Logistic EuroSCORE Predict Outcomes Following Transcatheter Aortic Valve Replacement at 30 Days: the Milan Experience 47
Comparison of paclitaxel drug-eluting balloon and paclitaxel-eluting stent in small coronary vessels in diabetic and nondiabetic patients â results from the BELLO (balloon elution and late loss optimization) trial 47
Does geographical variability influence five-year MACCE rates in the multicentre SYNTAX revascularisation trial? 46
Observed versus predicted mortality after MitraClip treatment in patients with symptomatic heart failure and significant functional mitral regurgitation 46
How should i treat recurrent restenosis with underexpanded multilayered struts after repeated complex bifurcation stenting? 46
Long-term outcomes of rotational atherectomy for the percutaneous treatment of chronic total occlusions 46
Impact of design of coronary stents and length of dual antiplatelet therapies on ischaemic and bleeding events: a network meta-analysis of 64 randomized controlled trials and 102 735 patients 46
Effect of valve design and anticoagulation strategy on 30-day clinical outcomes in transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial 46
The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent 46
First Experience With the Coronary Sinus Reducer System for the Management of Refractory Angina in Patients Without Obstructive Coronary Artery Disease 46
The Evolution From Surgery to Percutaneous Mitral Valve Interventions The Role of the Edge-to-Edge Technique 46
Transradial versus transfemoral ancillary approach in complex structural, coronary, and peripheral interventions. Results from the multicenter ancillary registry: A study of the Italian Radial Club 46
Trans-subclavian versus transapical access for transcatheter aortic valve implantation: A multicenter study 46
Expansion in calcific lesions and overall clinical outcomes following bioresorbable scaffold implantation optimized with intravascular ultrasound 45
Anesthetic Management of Cardioband Implantation: Data From a Preliminary Experience and New Insights 45
The ratio of contrast volume to glomerular filtration rate predicts acute kidney injury and mortality after transcatheter aortic valve implantation 45
Ivabradine in Patients with Stable Coronary Artery Disease: A Rationale for Use in Addition to and Beyond Percutaneous Coronary Intervention 45
Use of edge-to-edge percutaneous mitral valve repair for severe mitral regurgitation in cardiogenic shock: A multicenter observational experience (MITRA-SHOCK study) 44
Percutaneous suture-based patent foramen ovale closure: A state-of-the-art review 44
Bioresorbable Vascular Scaffolds as a Treatment Option for Left Main Lesions 44
Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry 44
Totale 5.590
Categoria #
all - tutte 67.255
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.255


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 0 0 3
2021/202222 1 0 0 6 0 0 1 5 0 1 7 1
2022/2023401 9 4 8 24 22 11 2 10 48 38 207 18
2023/20241.675 106 80 386 139 128 312 77 73 25 55 133 161
2024/20252.310 70 5 7 37 53 305 159 129 464 620 253 208
2025/20266.052 913 411 275 499 214 314 1.867 226 343 421 272 297
Totale 10.498